587 related articles for article (PubMed ID: 28475119)
21. Ghrelin receptor agonist, GHRP-2, attenuates burn injury-induced MuRF-1 and MAFbx expression and muscle proteolysis in rats.
Sheriff S; Joshi R; Friend LA; James JH; Balasubramaniam A
Peptides; 2009 Oct; 30(10):1909-13. PubMed ID: 19577604
[TBL] [Abstract][Full Text] [Related]
22. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
[TBL] [Abstract][Full Text] [Related]
23. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
[TBL] [Abstract][Full Text] [Related]
24. Role of NF-kappaB and cytokine in experimental cancer cachexia.
Zhou W; Jiang ZW; Tian J; Jiang J; Li N; Li JS
World J Gastroenterol; 2003 Jul; 9(7):1567-70. PubMed ID: 12854165
[TBL] [Abstract][Full Text] [Related]
25. Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.
Zhang H; Garcia JM
Expert Opin Pharmacother; 2015 Jun; 16(8):1245-53. PubMed ID: 25945893
[TBL] [Abstract][Full Text] [Related]
26. Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice.
Siddiqui RA; Hassan S; Harvey KA; Rasool T; Das T; Mukerji P; DeMichele S
Br J Nutr; 2009 Oct; 102(7):967-75. PubMed ID: 19393114
[TBL] [Abstract][Full Text] [Related]
27. Control of food intake and muscle wasting in cachexia.
Amitani M; Asakawa A; Amitani H; Inui A
Int J Biochem Cell Biol; 2013 Oct; 45(10):2179-85. PubMed ID: 23911307
[TBL] [Abstract][Full Text] [Related]
28. Muscle and serum metabolomes are dysregulated in colon-26 tumor-bearing mice despite amelioration of cachexia with activin receptor type 2B ligand blockade.
Lautaoja JH; Lalowski M; Nissinen TA; Hentilä J; Shi Y; Ritvos O; Cheng S; Hulmi JJ
Am J Physiol Endocrinol Metab; 2019 May; 316(5):E852-E865. PubMed ID: 30860875
[TBL] [Abstract][Full Text] [Related]
29. Clinical application of ghrelin.
Strasser F
Curr Pharm Des; 2012; 18(31):4800-12. PubMed ID: 22632860
[TBL] [Abstract][Full Text] [Related]
30. Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice.
van Norren K; Kegler D; Argilés JM; Luiking Y; Gorselink M; Laviano A; Arts K; Faber J; Jansen H; van der Beek EM; van Helvoort A
Br J Cancer; 2009 Mar; 100(5):713-22. PubMed ID: 19259092
[TBL] [Abstract][Full Text] [Related]
31. Orally administered δ opioid agonist peptide rubiscolin-6 stimulates food intake in aged mice with ghrelin resistance.
Miyazaki Y; Kaneko K; Iguchi S; Mizushige T; Kanamoto R; Yoshikawa M; Shimizu T; Ohinata K
Mol Nutr Food Res; 2014 Oct; 58(10):2046-52. PubMed ID: 25047666
[TBL] [Abstract][Full Text] [Related]
32. Conjugated linoleic acid preserves gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma.
Graves E; Hitt A; Pariza MW; Cook ME; McCarthy DO
Res Nurs Health; 2005 Feb; 28(1):48-55. PubMed ID: 15625711
[TBL] [Abstract][Full Text] [Related]
33. Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice.
Asp ML; Tian M; Wendel AA; Belury MA
Int J Cancer; 2010 Feb; 126(3):756-63. PubMed ID: 19634137
[TBL] [Abstract][Full Text] [Related]
34. Astaxanthin Ameliorates Skeletal Muscle Atrophy in Mice With Cancer Cachexia.
Yu X; Ren P; Yang R; Yue H; Tang Q; Xue C
Nutr Cancer; 2024; 76(6):529-542. PubMed ID: 38567899
[TBL] [Abstract][Full Text] [Related]
35. Cancer anorexia and cachexia.
Tisdale MJ
Nutrition; 2001 May; 17(5):438-42. PubMed ID: 11377146
[TBL] [Abstract][Full Text] [Related]
36. Administration of adiponectin receptor agonist AdipoRon relieves cancer cachexia by mitigating inflammation in tumour-bearing mice.
Massart IS; Kouakou AN; Pelet N; Lause P; Schakman O; Loumaye A; Abou-Samra M; Deldicque L; Bindels LB; Brichard SM; Thissen JP
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):919-933. PubMed ID: 38572511
[TBL] [Abstract][Full Text] [Related]
37. Growth hormone releasing peptide 2 reverses anorexia associated with chemotherapy with 5-fluoruracil in colon cancer cell-bearing mice.
Perboni S; Bowers C; Kojima S; Asakawa A; Inui A
World J Gastroenterol; 2008 Nov; 14(41):6303-5. PubMed ID: 19009643
[TBL] [Abstract][Full Text] [Related]
38. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate.
Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC
Semin Oncol; 1998 Apr; 25(2 Suppl 6):45-52. PubMed ID: 9625383
[TBL] [Abstract][Full Text] [Related]
39. Effect of iguratimod and other anti-rheumatic drugs on adenocarcinoma colon 26-induced cachexia in mice.
Tanaka K; Urata N; Mikami M; Ogasawara M; Matsunaga T; Terashima N; Suzuki H
Inflamm Res; 2007 Jan; 56(1):17-23. PubMed ID: 17334666
[TBL] [Abstract][Full Text] [Related]
40. Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.
Siddiqui JA; Pothuraju R; Jain M; Batra SK; Nasser MW
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188359. PubMed ID: 32222610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
